Millrace Asset Group’s Tandem Diabetes Care TNDM Stock Holding History

Millrace Asset Group’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.96M	Buy	+46,304	New	+$1.96M	1.99%	18
2023 Q4	–	Sell	-54,706	Closed	-$1.14M	–	82
2023 Q3	$1.14M	Buy	+54,706	New	+$1.5M	1.4%	37
2023 Q2	–	Sell	-44,767	Closed	-$1.82M	–	64
2023 Q1	$1.82M	Sell	44,767 -11,444	-20%	-$474K	2.12%	20
2022 Q4	$2.53M	Buy	+56,211	New	+$2.54M	2.87%	10
2020 Q4	–	Sell	-7,448	Closed	-$845K	–	88
2020 Q3	$845K	Sell	7,448 -8,659	-54%	-$910K	0.68%	67
2020 Q2	$1.59M	Buy	+16,107	New	+$1.29M	1.63%	23
2019 Q1	–	Sell	-54,590	Closed	-$2.07M	–	69
2018 Q4	$2.07M	Sell	54,590 -410	-0.7%	-$14.5K	1.9%	18
2018 Q3	$2.36M	Sell	55,000 -105,000	-66%	-$3.67M	1.84%	19
2018 Q2	$3.52M	Sell	160,000 -340,000	-68%	-$4.18M	2.69%	1
2018 Q1	$2.48M	Buy	+500,000	New	+$1.61M	2.4%	8

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millrace Asset Group's TNDM Position: Q3 2024 in Review

Millrace Asset Group opened a new position in Tandem Diabetes Care (TNDM) in Q3 2024: 46,304 shares worth $1.96M. The stake represents 1.99% of the portfolio and ranks #18 among its holdings. This is a return to the name: Millrace Asset Group previously reported a position in TNDM as recently as Q3 2023.

Millrace Asset Group first reported a position in TNDM in Q1 2018 and has held it in 10 quarters since. The position peaked at $3.52M in Q2 2018. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

Millrace Asset Group held 46,304 shares of Tandem Diabetes Care worth $1.96M as of Q3 2024.
Tandem Diabetes Care was a new Millrace Asset Group position in Q3 2024.
Tandem Diabetes Care made up 1.99% of Millrace Asset Group's portfolio in Q3 2024, its #18 holding.
Millrace Asset Group first reported a position in Tandem Diabetes Care in Q1 2018 and has held it in 10 quarters since.
Millrace Asset Group's Tandem Diabetes Care position peaked at $3.52M in Q2 2018.
332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Millrace Asset Group's 13F filing for Q3 2024, filed 13 Nov 2024.